Vir Biotechnology, Inc
Insiders
Last 12 monthsSales planned on beside the trades reported on , and whether each names a .
Planned ·
$30.6M
34 notices · 4,289,900 sh
Oct 2025 to Oct 2026
Reported ·
$18.0M
49 sales · 0 buys
Oct 2025 to Jun 2026
The two figures cover different periods.
All 49 reported sales carry the 10b5-1 box. Together they are 1.65% of the shares on issue.
under a no plan named▼ salesize is dollars
Form 144 notices, newest first
2026-09-17O'Byrne Jason, EVP & Chief Financial Officer$212,927
2026-09-09O'Byrne Jason, EVP & Chief Financial Officer$315,241
2026-08-25O'Byrne Jason, EVP & Chief Financial Officer$242,591
2026-08-24O'Byrne Jason, EVP & Chief Financial Officer$142,124
2026-08-21O'Byrne Jason, EVP & Chief Financial Officer$245,297
2026-06-29Ramasastry Saira, Former Director$165,139
2026-06-01Sabatini Brent, SVP, Chief Accounting Officer$3,582
Form 4, 2026-06-02: sold 379 at $9.45 Form 4 ↗
2026-06-01Napolitano Janet, Director$30,240
Form 4, 2026-06-02: sold 3,200 at $9.45 Form 4 ↗
2026-04-30Eisner Mark, EVP and Chief Medical Officer$916,267
2026-04-06De Backer Marianne, President and CEO$664,343
Form 4, 2026-04-07: sold 72,559 at $9.16 Form 4 ↗
2026-03-23Sabatini Brent, SVP, Chief Accounting Officer$70,324
Form 4, 2026-03-24: sold 7,711 at $9.12 Form 4 ↗
2026-03-02VICKI LEE SATO, Director$799,920
Form 4, 2026-03-03: sold 22,000 at $9.50 Form 4 ↗
2026-02-25de Verneuil Vanina, EVP, General Counsel, Corp Sec$134,534
2026-02-25Eisner Mark, EVP and Chief Medical Officer$18,550
2026-02-25SVF Endurance (Cayman) Limited, Stockholder$3,796,000
2026-02-24Eisner Mark, EVP and Chief Medical Officer$15,405
Form 4, 2026-02-26: sold 3,505 at $9.69 Form 4 ↗
2026-02-24De Backer Marianne, President and CEO$140,720
Form 4, 2026-02-26: sold 14,762 at $9.53 Form 4 ↗
2026-02-24O'Byrne Jason, EVP & Chief Financial Officer$15,576
Form 4, 2026-02-26: sold 1,634 at $9.53 Form 4 ↗
2026-02-24Sabatini Brent, SVP, Chief Accounting Officer$13,632
Form 4, 2026-02-26: sold 1,430 at $9.53 Form 4 ↗
2026-02-24de Verneuil Vanina, EVP, General Counsel, Corp Sec$29,713
Form 4, 2026-02-26: sold 16,817 at $9.77 Form 4 ↗
2026-02-24VICKI LEE SATO, Director$151,401
Form 4, 2026-02-26: sold 42,377 at $9.75 Form 4 ↗
2026-02-23O'Byrne Jason, EVP & Chief Financial Officer$15,569
Form 4, 2026-02-24: sold 2,089 at $7.45 Form 4 ↗
2026-02-23Eisner Mark, EVP and Chief Medical Officer$15,569
Form 4, 2026-02-24: sold 2,089 at $7.45 Form 4 ↗
2026-02-23De Backer Marianne, President and CEO$141,894
Form 4, 2026-02-24: sold 19,039 at $7.45 Form 4 ↗
2026-02-23de Verneuil Vanina, EVP, General Counsel, Corp Sec$33,128
Form 4, 2026-02-24: sold 4,445 at $7.45 Form 4 ↗
2026-02-23Sabatini Brent, SVP, Chief Accounting Officer$13,631
Form 4, 2026-02-24: sold 1,829 at $7.45 Form 4 ↗
2026-02-13Sabatini Brent, SVP, Chief Accounting Officer$11,918
Form 4, 2026-02-18: sold 1,530 at $7.79 Form 4 ↗
2026-01-14SVF Endurance (Cayman) Limited, Stockholder$8,533,886
2026-01-02VICKI LEE SATO, Director$397,980
Form 4, 2026-01-05: sold 22,000 at $5.93 Form 4 ↗
2025-11-25SVF Endurance (Cayman) Limited, 10% Stockholder$8,058,391
Form 4, 2025-12-01: sold 189,431 at $6.41 Form 4 ↗
2025-11-17O'Byrne Jason, EVP & Chief Financial Officer$37,781
Form 4, 2025-11-18: sold 6,799 at $5.56 Form 4 ↗
2025-11-05de Verneuil Vanina, EVP, General Counsel, Corp Sec$12,307
Form 4, 2025-11-07: sold 2,385 at $5.16 Form 4 ↗
2025-11-03de Verneuil Vanina, EVP, General Counsel, Corp Sec$8,003
Form 4, 2025-11-04: sold 1,365 at $5.86 Form 4 ↗